Thus, it will be important for future work to determine the predictive value of stromal TGFβR2 in prostate cancer, and to delineate the molecular mechanisms underpinning tumor progression in the context of TGFβR2 stromal loss. The gene discussed is TGFBR2; the disease is prostate carcinoma.